Literature DB >> 24548650

Analyses of longitudinal and of transverse right ventricular function provide different clinical information in patients with pulmonary hypertension.

Silvia Pica1, Stefano Ghio2, Gianni Tonti3, Rita Camporotondo1, Annalisa Turco1, Anna Sara Pazzano1, Laura Scelsi1, Claudia Raineri1, Luigi Oltrona Visconti1.   

Abstract

We tested the hypothesis that analysis of longitudinal right ventricular (RV) function and analysis of transverse RV function by echocardiography provide different clinical information in patients with pulmonary hypertension (PH). Indices of longitudinal and transverse RV function were obtained with different echocardiographic techniques in 30 patients with idiopathic pulmonary arterial hypertension, 28 patients with systolic left ventricular dysfunction and PH (sLVD PH), 27 patients with sLVD and normal pulmonary pressure (sLVD no PH) undergoing right heart catheterization and 20 healthy patients. Indices of RV transverse function were significantly worse in patients with PH than in patients without PH and did not statistically differ between patients with normal and those with reduced cardiac index; RV diameter shortening at mid-segment correlated best with mean pulmonary artery pressure (h = 0.63, p < 0.001). Indices of longitudinal function were poorly related to severity of PH, but a tricuspid annular plane systolic excursion <15 mm predicted a cardiac index <2.5 L/min/m(2) with 80% sensitivity and 93% specificity (area under curve = 0.85). In conclusion, in patients with PH, reduced transverse RV function is a reliable indicator of the presence of high pulmonary artery pressure, whereas reduced RV longitudinal function is associated with impairment of cardiac function.
Copyright © 2014 World Federation for Ultrasound in Medicine & Biology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Echocardiography; Pulmonary hypertension; Right ventricle

Mesh:

Year:  2014        PMID: 24548650     DOI: 10.1016/j.ultrasmedbio.2013.12.005

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  6 in total

1.  Accuracy of the ClearSight™ system in patients undergoing abdominal aortic aneurysm surgery.

Authors:  Miho Sumiyoshi; Takuma Maeda; Erika Miyazaki; Naoshi Hotta; Hitoshi Sato; Eisuke Hamaguchi; Hiroko Kanazawa; Yoshihiko Ohnishi; Masataka Kamei
Journal:  J Anesth       Date:  2019-03-23       Impact factor: 2.078

2.  Low cardiac index is associated with incident dementia and Alzheimer disease: the Framingham Heart Study.

Authors:  Angela L Jefferson; Alexa S Beiser; Jayandra J Himali; Sudha Seshadri; Christopher J O'Donnell; Warren J Manning; Philip A Wolf; Rhoda Au; Emelia J Benjamin
Journal:  Circulation       Date:  2015-02-19       Impact factor: 29.690

3.  IMproving PULmonary hypertension Screening by Echocardiography: IMPULSE.

Authors:  Oliver Graham Slegg; James Alexander Willis; Fiona Wilkinson; Joseph Sparey; Christopher Basil Wild; Jennifer Rossdale; Robert Mackenzie Ross; John D Pauling; Kevin Carson; Sri Raveen Kandan; David Oxborough; Daniel Knight; Oliver James Peacock; Jay Suntharalingam; John Gerard Coghlan; Daniel Xavier Augustine
Journal:  Echo Res Pract       Date:  2022-10-19

4.  Longitudinal and transverse right ventricular function in pulmonary hypertension: cardiovascular magnetic resonance imaging study from the ASPIRE registry.

Authors:  Andrew J Swift; Smitha Rajaram; Dave Capener; Charlie Elliot; Robin Condliffe; Jim M Wild; David G Kiely
Journal:  Pulm Circ       Date:  2015-09       Impact factor: 3.017

5.  Pulmonary hypertension attenuates the dynamic preload indicators increase during experimental hypovolemia.

Authors:  Juan P Bouchacourt; Juan Riva; Juan C Grignola
Journal:  BMC Anesthesiol       Date:  2017-03-03       Impact factor: 2.217

Review 6.  Pulmonary Hypertension and Indicators of Right Ventricular Function.

Authors:  Célia von Siebenthal; John-David Aubert; Periklis Mitsakis; Patrick Yerly; John O Prior; Laurent Pierre Nicod
Journal:  Front Med (Lausanne)       Date:  2016-06-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.